Karapinar, Tuba HilkayOymak, YesimEcevit, CigdemYilmaz, FundaKarakoyun, MirayAy, YilmazVergin, Canan2019-10-272019-10-2720152147-94452147-9445https://doi.org/10.4274/jpr.69885https://hdl.handle.net/11454/51971The association between 6-Thioguanine (6-TG) treatment and drug-induced liver injury has been reported since 1976. Recent reports have suggested that treatment of patients with 6-TG can lead to chronic hepatotoxicity and portal hypertension. Most of the cases reported to have 6-TG related hepatotoxicity had acute lymphoblastic leukemia or inflammatory bowel disease. In this case report, we discussed the diagnosis and approach in an acute myeloid leukemia patient who developed 6-TG related chronic hepatotoxicity.tr10.4274/jpr.69885info:eu-repo/semantics/openAccess6-ThioguaninehepatotoxicityleukemiaArticle22102104WOS:000219056100012N/A